Petros Pharmaceuticals Partners with Leading Global Contract Manufacturer to Bring Production of Erectile Dysfunction Drug STENDRAÒ (avanafil) to the United States |
NEW YORK, Jan. 24, 2022 /PRNewswire/ -- Petros Prescription drugs, Inc. ("Petros" or "the Firm") (Nasdaq: PTPI), a number one ...